Quest Diagnostics
560 hedge funds and large institutions have $10.4B invested in Quest Diagnostics in 2016 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 172 increasing their positions, 212 reducing their positions, and 43 closing their positions.
29% more call options, than puts
Call options by funds: $31.9M | Put options by funds: $24.7M
19% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 43
0% more funds holding
Funds holding: 558 → 560 (+2)
0% less capital invested
Capital invested by funds: $10.5B → $10.4B (-$36.1M)
2.21% less ownership
Funds ownership: 90.98% → 88.78% (-2.2%)
19% less repeat investments, than reductions
Existing positions increased: 172 | Existing positions reduced: 212
73% less funds holding in top 10
Funds holding in top 10: 11 → 3 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$48.9M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$44.5M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$38.8M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$37.8M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$30.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
-$255M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$149M |
| 3 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
-$85.3M |
| 4 |
HM
HealthCor Management
New York
|
-$83.2M |
| 5 |
PFC
Poplar Forest Capital
Pasadena,
California
|
-$48.8M |
DGX Hedge Fund Activity: Q3 2016 in Review
560 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2016, worth a combined $10.4B — down 0.34% from $10.5B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new DGX positions and 43 closed out — a net gain of 8 holders — while 172 added to existing stakes and 212 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $48.9M. The largest seller was Davis Selected Advisers, cutting an estimated $255M.
- 560 institutional investors held Quest Diagnostics (DGX) as of Q3 2016, up from 558 in Q2 2016.
- Funds reported $10.4B of Quest Diagnostics stock for Q3 2016, down 0.34% quarter-over-quarter.
- 51 funds opened new Quest Diagnostics positions in Q3 2016 and 43 closed out, a net change of +8 holders.
- The largest Quest Diagnostics buyer in Q3 2016 was OppenheimerFunds, an estimated $48.9M added.
- The largest Quest Diagnostics seller in Q3 2016 was Davis Selected Advisers, an estimated $255M sold.
Based on aggregated 13F filings for Q3 2016.